1[1]Henderson VW, Paganini-Hill A, Emanuel CK, et al. Estrogen replace-ment therapy in older women: comparisons between Alzheimer's disease cases and non-demented control subjects. Arch Neurol,1994; 51:896～900.
2[2]Lerner A, Cole R, Debanne S, et al. Immunological and endocrine conditions in an Alzheimer's disease case-control study [abstract]. Neuroepidemiology, 1995; 14:307.
3[3]Jorn AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative intergration of the literature. Acta Psychiatr Scand, 1987; 76:465～479.
4[4]Woolley CS, McEwen BS. Roles of estradiol and progeserone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol, 1993;336:293～306.
5[5]Jaffe AB, Toran-Allerand CD, Greengard P, et al. Estrogen regulates metabolism of Alzheimer amyloid b precursor protein. J Biol Chem, 1994; 269:13065～13068.
6[6]Newcomer JW, Craft S, Hershey T, et al. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci, 1994;14:2047～2053.
7[7]Henderson VW. Estrogen, cognition, and a woman's risk of Alzheimer's disease. Am J Med, 1997; 103:11s～18s.
8[4]Tan J, Town T, Mori T,et al. CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase[J].J Neurosci,2000,20(20):7587-7594.
9[5]Casamenti F, ProsPeri C, Scali C,et al. Interleukin-l beta activates forebrain gial and increases nitrc oxide production and GABA release in vivo: implicahons for Alzheimer disease.[J]Neuposi,1999,91(3)831-842.
10[6]Zhang SC. Neuron-miccroglia interachon in vitro.[J] Acta Neuropathol,1996,91:385-395.
